The effect of anti-inflammatory drugs on vascular smooth muscle.
D000632:Aminopyrine / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000983:Antipyrine / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002738:Chloroquine / Q000494:pharmacology; D046508:Culture Techniques; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005439:Flufenamic Acid / Q000494:pharmacology; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists; D006854:Hydrocortisone / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects; D008642:Mesenteric Veins / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats; D012459:Salicylates / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000037:antagonists & inhibitors*
D000893:Anti-Inflammatory Agents; D001565:Benzoates; D006634:Histamine H1 Antagonists; D012459:Salicylates; D014662:Vasoconstrictor Agents; D000632:Aminopyrine; D005439:Flufenamic Acid; D002738:Chloroquine; D010653:Phenylbutazone; D001920:Bradykinin; D000983:Antipyrine; D006854:Hydrocortisone; D009638:Norepinephrine; D007213:Indomethacin; D004837:Epinephrine